These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24303091)

  • 1. Increased bone mineral density in patients with non-alcoholic steatohepatitis.
    Kaya M; Işık D; Beştaş R; Evliyaoğlu O; Akpolat V; Büyükbayram H; Kaplan MA
    World J Hepatol; 2013 Nov; 5(11):627-34. PubMed ID: 24303091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents.
    Mosca A; Fintini D; Scorletti E; Cappa M; Paone L; Zicari AM; Nobili V; Byrne CD
    Liver Int; 2018 Dec; 38(12):2301-2308. PubMed ID: 30176114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease.
    Pacifico L; Bezzi M; Lombardo CV; Romaggioli S; Ferraro F; Bascetta S; Chiesa C
    World J Gastroenterol; 2013 Jul; 19(25):4007-14. PubMed ID: 23840146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Prevalence of Hormonal Changes and Hepatic Osteodystrophy in Frail Patients with Cirrhosis-An Observational Study.
    Singh S; Taneja S; Tandon P; De A; Verma N; Premkumar M; Duseja A; Dhiman RK; Singh V
    J Clin Exp Hepatol; 2022; 12(3):800-807. PubMed ID: 35677501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.
    Kargiotis K; Athyros VG; Giouleme O; Katsiki N; Katsiki E; Anagnostis P; Boutari C; Doumas M; Karagiannis A; Mikhailidis DP
    World J Gastroenterol; 2015 Jul; 21(25):7860-8. PubMed ID: 26167086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease.
    Nobili V; Giorgio V; Liccardo D; Bedogni G; Morino G; Alisi A; Cianfarani S
    Eur J Endocrinol; 2014 Apr; 170(4):547-53. PubMed ID: 24412930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].
    Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density in patients with nonalcoholic steatohepatitis among end-stage liver disease patients awaiting liver transplantation.
    Boonchaya-anant P; Hardy E; Borg BB; Burshell AL
    Endocr Pract; 2013; 19(3):414-9. PubMed ID: 23337159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis.
    Le TA; Loomba R
    J Clin Exp Hepatol; 2012 Jun; 2(2):156-73. PubMed ID: 25755424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased Bone Mineral Density at the Femoral Neck and Lumbar Spine in South Indian Patients with Type 2 Diabetes.
    Mathen PG; Thabah MM; Zachariah B; Das AK
    J Clin Diagn Res; 2015 Sep; 9(9):OC08-12. PubMed ID: 26500934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of vitamin D status bone mineral density and dental health in children with cholestasis.
    Samra NM; Emad El Abrak S; El Dash HH; El Said El Raziky M; El Sheikh MA
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):368-377. PubMed ID: 29551613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease].
    Christ E; Linka A; Junga G; Odermatt M; Steinert H; Kiowski W; Schmid C
    Schweiz Med Wochenschr; 1996 Sep; 126(37):1553-9. PubMed ID: 8927958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia.
    Terzi R; Dindar S; Terzi H; Demirtaş Ö
    Metab Syndr Relat Disord; 2015 Mar; 13(2):78-83. PubMed ID: 25470355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
    Laway BA; Goswami R; Singh N; Gupta N; Seith A
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):405-9. PubMed ID: 16584512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial.
    Portillo-Sanchez P; Bril F; Lomonaco R; Barb D; Orsak B; Bruder JM; Cusi K
    J Diabetes; 2019 Mar; 11(3):223-231. PubMed ID: 30073778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.